This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd., Ning Bo Hongshuo Electronics & Appliance Co., Ltd., Shaoxing Versailtex Co., Ltd.. Active years: 2015-2025.
Company Filing History:
2 out of 4 
1 out of 1 
1 out of 1 Years Active: 2015-2025
Title: Innovations of Inventor Li Fang
Introduction
Li Fang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of GLP-1 receptor agonists. With a total of 4 patents, his work is aimed at addressing various metabolic disorders, including type 2 diabetes.
Latest Patents
Li Fang's latest patents include innovative formulations that enhance the efficacy of GLP-1 receptor agonists. One of his notable inventions is the crystalline form A of GLP-1 receptor agonist, which relates to a specific crystal form of a compound known as OAD2. This invention outlines methods of preparation that may be beneficial in treating conditions such as type 2 diabetes. Another significant patent involves pharmaceutically acceptable acid salts of OAD2, which also aims to provide therapeutic benefits for metabolic disorders.
Career Highlights
Throughout his career, Li Fang has worked with prominent companies in the pharmaceutical industry. He has been associated with Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. and Shaoxing Versailtex Co., Ltd. His work in these organizations has contributed to advancements in drug formulation and development.
Collaborations
Li Fang has collaborated with several professionals in his field, including Haiwen Hu and Fan Hu. These collaborations have fostered innovation and have been instrumental in the successful development of his patented inventions.
Conclusion
Li Fang's contributions to the pharmaceutical industry through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for metabolic disorders, showcasing the importance of innovation in healthcare.